Sophia Hsin-Jung Li is an early biotech investor with over ten years of experience in life science research. Sophia serves as the Life Science Lead at TechU Ventures, where she focuses on building investment portfolios in early platform-based healthcare, biotech and food tech startups.

With her expertise in science and technology, she can understand the values of new findings at a deep level and effectively communicate the knowledge to audiences from other backgrounds. Sophia wants to use her technical skills to help startups become successful from the ground up. 

Sophia holds a Doctor of Philosophy in Molecular Biology from Princeton University, specializing in microbiology and biochemistry. Her thesis describes a novel translational control in E. coli under metabolic restrictions. She also published the first protocol for human mitochondrial ribosome profiling. She has a Bachelor of Science double-majoring in Chemical Engineering and Biology from MIT with an emphasis in cancer biology and biophysics. She did her postdoc training in Stem Cell Bioengineering at EPFL in Switzerland, where she developed a tissue-engineered mini-gut for studying host-microbe interactions.

Sophia is helping us create our first ever patent strategy fellowship and will actively be working in the areas of patent portfolio management and educational content development.